#TogetherAgainstCOVID19 – EuropaBio Interview with Finnish Bioindustries

Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases

Blueprint Genetics expands in North America by building a new CLIA/CAP NGS facility in Seattle

DelSiTech Ltd Receives Significant Funding for Developing Long-Acting Injectables for contraceptives and HIV antivirals development by the Bill & Melinda Gates Foundation

Helsinki Biobank and Fimmic Introduce a Unique One Access Service for Biomedical Research

Life Science Mentors – Mentoring Service for Finnish Life Science Actors

Faron Pharmaceuticals Admission to AIM and first day of dealings £10 million fundraise to progress Phase III clinical trial

Faron Enters Agreement with Selexis SA to Progress Development of Novel Cancer Immunotherapy Clevegen